Related Experiment Video
Updated: Jul 5, 2026

Tissue Engineering of the Intestine in a Murine Model
Published on: December 1, 2012
Morbidity and mortality of short-bowel syndrome in infants with abdominal wall defects
Anjani Thakur1, Charles Chiu, Ruben E Quiros-Tejeira
1Department of Pediatrics, UCLA School of Medicine, Los Angeles, Californlia 90095, USA.
Insights
Total parenteral nutrition (TPN) improves survival for infants with short-bowel syndrome (SBS) from gastroschisis or omphalocele. Remaining bowel length significantly impacts survival rates and duration of TPN dependency.
Area of Science:
- Pediatric Surgery
- Gastroenterology
- Neonatology
Background:
- Infants with gastroschisis or omphalocele often experience small intestinal loss, necessitating Total Parenteral Nutrition (TPN).
- Long-term TPN use and shortened gut complications can limit quality and length of life for these patients.
- Short-bowel syndrome (SBS) presents significant morbidity and mortality challenges in affected infants.
Purpose of the Study:
- To identify factors influencing morbidity and mortality in infants with SBS due to gastroschisis or omphalocele.
- To evaluate the impact of residual bowel length and abdominal closure techniques on patient outcomes.
Main Methods:
- Retrospective chart review of 850 infants receiving TPN between 1977 and 1999.
- Detailed analysis of 17 identified infants with SBS, gastroschisis, or omphalocele, focusing on those with >3 months of TPN.
- Recorded data included diagnosis, surgical procedures, bowel length, TPN weaning, growth, and developmental progress.
Main Results:
- Overall survival rate was 76% (13/17).
- Survival correlated with remaining bowel length: 86% for >15 cm vs. 33% for <15 cm (P=0.05).
- Hepatic dysfunction from TPN contributed to mortality in 3 of 4 non-survivors.
- Tight abdominal closure was implicated in bowel necrosis and SBS in 10/17 patients.
- Longer residual bowel (>38 cm) significantly reduced TPN duration (1 year vs. 10 years for <38 cm).
Conclusions:
- Tight abdominal closure in gastroschisis/omphalocele may lead to bowel necrosis and SBS.
- Residual small bowel length is a critical determinant of survival and TPN duration in SBS.
- TPN remains vital for improving long-term survival and quality of life in infants with SBS.
Abstract:
Total parenteral nutrition (TPN) has made survival beyond infancy possible for many infants who have sustained small intestinal loss as a result of gastroschisis or omphalocele. The length and quality of life in these patients have often been limited by the development of late sequelae secondary both to the protracted use of TPN and the long-term complications of a shortened gut. This study was undertaken to determine what factors influence the morbidity and mortality of short-bowel syndrome (SBS) due to gastroschisis or omphalocele. A retrospective chart review of 850 infants who received TPN from January 1977 through December 1999 was carried out. All infants were treated at one academic medical center; those who had received > or =3 months of TPN were further segregated and their diagnosis, surgical procedures, length of bowel, ability to wean from TPN, follow-up weight and height, and developmental progress were recorded. Seventeen children were identified with SBS and either gastroschisis or omphalocele. Tight primary or secondary closure of the abdominal wall was believed to be a major cause of bowel necrosis and SBS in at least ten of the 17 patients. Overall survival was 76 per cent (13/17); survival was correlated with length of remaining bowel and was 86 per cent in patients having more than 15 cm of small bowel remaining but only 33 per cent in patients with less than 15 cm of small bowel remaining (P = 0.05). A longer length of residual small bowel resulted in a significantly shorter duration of TPN with a mean duration of 1.0 year for survivors having >38 cm and 10.0 years for survivors with <38 cm of bowel remaining (P = 0.03). Hepatic dysfunction with progressive failure resulting from TPN was related to death in three of the four nonsurvivors. The presence or absence of an ileocecal valve appeared unrelated both to the success of TPN weaning and to the length of time on TPN (P > 0.2). Eight of the 13 survivors have no ileocecal valve; five have undergone >50 per cent colonic resection. Nine of the survivors have adapted to enteral feedings (mean 36 +/- 60 months) during which time weaning from TPN occurred. The mean age of survivors is 7.9 +/- 5.1 years. Near-normal weights (defined as exceeding the fifth percentile for weight) were achieved for 92 per cent of the patients (12/13) with 46 per cent of the patients (6/13) exceeding the 50th percentile. Near-normal heights (exceeding the fifth percentile) were achieved for 77 per cent of the patients (10/13) with 15 per cent of the patients (2/13) exceeding the 50th percentile. Quality of life was measured on the basis of return to public school: nine of ten school-age survivors attend school and eight are normal without signs of developmental delay. Tight abdominal closure of gastroschisis or omphalocele may cause bowel necrosis and SBS. TPN has improved the long-term survival and quality of life in infants with SBS.
Related Concept Videos
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...
Inflammatory Bowel Disease V: Surgical Management
Here are some common surgical interventions for IBD:
Intestinal Obstruction II: Pathophysiology

